Items where authors include "Parker, C."

Article

Perri, G. orcid.org/0000-0002-3208-1197, Mathers, J.C., Martin-Ruiz, C. et al. (8 more authors) (2024) Selenium status and its determinants in very old adults: insights from the Newcastle 85+ Study. British Journal of Nutrition, 131 (5). pp. 901-910. ISSN 0007-1145

Heaven, A. orcid.org/0000-0003-2959-2241, Bower, P., Day, F. et al. (12 more authors) (2024) PeRsOnaliSed care Planning for oldER people with frailty (PROSPER): protocol for a randomised controlled trial. Trials, 25. 8. ISSN 1745-6215

Ford, A.C., Wright-Hughes, A., Alderson, S.L. et al. (65 more authors) (2023) Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. ISSN 0140-6736

Lee, I.T., Cosgrove, C.A., Moore, P. et al. (63 more authors) (2023) Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial. The Lancet Infectious Diseases. ISSN 1473-3099

Dearnaley, D., Hinder, V., Hijab, A. et al. (25 more authors) (2022) Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial. The Lancet Oncology, 23 (4). pp. 501-513. ISSN 1470-2045

Tai, F.W.D., Ellul, P., Elosua, A. et al. (10 more authors) (2021) Panenteric capsule endoscopy identifies proximal small bowel disease guiding upstaging and treatment intensification in Crohn's disease: a European multicentre observational cohort study. United European Gastroenterology Journal, 9 (2). pp. 248-255. ISSN 2050-6406

Sartor, O., Coleman, R.E. orcid.org/0000-0002-4275-1043, Nilsson, S. et al. (11 more authors) (2017) An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223. Annals of Oncology, 28 (5). pp. 1090-1097. ISSN 0923-7534

Nettle, D., Andrews, C., Reichert, S. et al. (6 more authors) (2017) Early-life adversity accelerates cellular ageing and affects adult inflammation: Experimental evidence from the European starling. Scientific Reports, 7. 40794.

Parker, C., Zhan, L., Cislo, P. et al. (6 more authors) (2017) Effect of radium-223 dichloride (Ra-223) on hospitalisation: An analysis from the phase 3 randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) trial. European Journal of Cancer, 71. C. pp. 1-6. ISSN 0959-8049

Parker, C., Finkelstein, S.E., Michalski, J.M. et al. (9 more authors) (2016) Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA Trial. European Urology, 70 (5). pp. 875-883. ISSN 0302-2838

Vogelzang, N.J., Coleman, R.E. orcid.org/0000-0002-4275-1043, Michalski, J.M. et al. (8 more authors) (2016) Hematologic Safety of Radium-223 Dichloride: Baseline Prognostic Factors Associated With Myelosuppression in the ALSYMPCA Trial. Clinical Genitourinary Cancer. ISSN 1558-7673

Sartor, O., Hoskin, P., Coleman, R.E. orcid.org/0000-0002-4275-1043 et al. (6 more authors) (2016) Chemotherapy following radium-223 dichloride treatment in ALSYMPCA. Prostate, 76 (10). pp. 905-916. ISSN 0270-4137

James, N., Pirrie, S., Pope, A. et al. (17 more authors) (2016) TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer. Health Technology Assessment, 20. 53. ISSN 1366-5278

Andronis, L., Goranitis, I., Pirrie, S. et al. (19 more authors) (2016) Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747). BJU International. ISSN 1464-4096

Nilsson, S., Cislo, P., Sartor, O. et al. (7 more authors) (2016) Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study. Annals of Oncology, 27 (5). pp. 868-874. ISSN 0923-7534

James, N.D., Pirrie, S.J., Pope, A.M. et al. (19 more authors) (2016) Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both. JAMA Oncology, 2 (4). p. 493. ISSN 2374-2437

Gott, M., Ingleton, C., Gardiner, C. et al. (8 more authors) (2013) Transitions to palliative care for older people in acute hospitals: a mixed-methods study. Health Services and Delivery Research, 1 (11). pp. 1-138. ISSN 2050-4349

Ryan, T., Ingleton, C., Gardiner, C. orcid.org/0000-0003-1785-7054 et al. (3 more authors) (2013) Symptom burden, palliative care need and predictors of physical and psychological discomfort in two UK hospitals. BMC PALLIATIVE CARE, 12. 11. ISSN 1472-684X

Small, N., Barnes, S., Gott, M. et al. (4 more authors) (2009) Dying, death and bereavement: a qualitative study of the views of carers of people with heart failure in the UK. BMC Palliative Care, 8 (1). p. 6. ISSN 1472-684X

Parker, C., Barnes, S., McKee, K. et al. (3 more authors) (2004) Quality of life and building design in residential and nursing homes for older people. Ageing and Society, 24 (6). pp. 941-962. ISSN 0144-686X